Endophthalmitis: A Case for Acting Early - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Endophthalmitis: A Case for Acting Early

Trial suggests early vitrectomy could deliver faster and greater visual recovery for patients with acute endophthalmitis

  • September 3, 2026

  • 3 min

Share

  • 1

    Acute endophthalmitis affects approximately 1 in 1,000–2,000 patients post-intraocular procedures, leading to severe visual impairment or blindness.

  • 2

    A Phase 2 study showed that early vitrectomy within 48–96 hours improved visual outcomes compared to conventional antibiotic treatment.

  • 3

    Patients who underwent early vitrectomy had a median improvement of 40 letters in vision, significantly higher than the 13 letters gained by the antibiotic-first group.

  • 4

    The early vitrectomy group experienced fewer non-serious adverse events and retinal detachments compared to those managed with antibiotics.

  • 5

    The study's findings support further investigation in a larger Phase 3 trial to confirm the benefits of early surgical intervention in endophthalmitis.

Original Source(s)

Endophthalmitis: A Case for Acting Early

  • September 3, 2026

Related Content

The Prevention Paradox

The Prevention Paradox: Glaucoma treatment asks patients, physicians, and payers to act before the consequences are visible.

Perspectives on Medicare’s Proposed iDose TR Coverage Policy

In May 2026, 5 Medicare Administrative Contractors released proposed Local Coverage Determinations (LCDs) addressing Medicare reimbursement for anterior-segment intraocular nonbiodegradable drug-eluting systems, a category that currently includes only the travoprost intracameral implant iDose TR (Glaukos). Many glaucoma specialists believe the proposed LCDs do not reflect contemporary glaucoma practice or the clinical rationale underlying sustained drug-delivery therapies. Glaucoma Physician spoke with several leading surgeons about the proposed LCDs, the reasons for their concerns, and the changes they believe would better reflect contemporary glaucoma practice.

Global Perspectives on Contact Lens Sales

Ryan McKinnis, OD, explores what US practices can learn from the emphasis on professional services and diverse regulatory models from contact lens sales from around the world.